234 related articles for article (PubMed ID: 9200069)
21. Increased neurovirulence and reactivation of the herpes simplex virus type 1 latency-associated transcript (LAT)-negative mutant dLAT2903 with a disrupted LAT miR-H2.
Jiang X; Brown D; Osorio N; Hsiang C; BenMohamed L; Wechsler SL
J Neurovirol; 2016 Feb; 22(1):38-49. PubMed ID: 26069184
[TBL] [Abstract][Full Text] [Related]
22. Transactivation of Herpes Simplex Virus 1 (HSV-1) Infected Cell Protein 4 Enhancer by Glucocorticoid Receptor and Stress-Induced Transcription Factors Requires Overlapping Krüppel-Like Transcription Factor 4/Sp1 Binding Sites.
Ostler JB; Thunuguntla P; Hendrickson BY; Jones C
J Virol; 2021 Jan; 95(4):. PubMed ID: 33208447
[TBL] [Abstract][Full Text] [Related]
23. Evidence for a bidirectional element located downstream from the herpes simplex virus type 1 latency-associated promoter that increases its activity during latency.
Berthomme H; Lokensgard J; Yang L; Margolis T; Feldman LT
J Virol; 2000 Apr; 74(8):3613-22. PubMed ID: 10729137
[TBL] [Abstract][Full Text] [Related]
24. Relationship between TATA-binding protein and herpes simplex virus type 1 ICP4 DNA-binding sites in complex formation and repression of transcription.
Kuddus R; Gu B; DeLuca NA
J Virol; 1995 Sep; 69(9):5568-75. PubMed ID: 7637002
[TBL] [Abstract][Full Text] [Related]
25. The tax protein of human T-cell leukemia virus type 1 mediates the transactivation of the c-sis/platelet-derived growth factor-B promoter through interactions with the zinc finger transcription factors Sp1 and NGFI-A/Egr-1.
Trejo SR; Fahl WE; Ratner L
J Biol Chem; 1997 Oct; 272(43):27411-21. PubMed ID: 9341193
[TBL] [Abstract][Full Text] [Related]
26. Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-beta type II receptor.
Du B; Fu C; Kent KC; Bush H; Schulick AH; Kreiger K; Collins T; McCaffrey TA
J Biol Chem; 2000 Dec; 275(50):39039-47. PubMed ID: 10982796
[TBL] [Abstract][Full Text] [Related]
27. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product.
Dey BR; Sukhatme VP; Roberts AB; Sporn MB; Rauscher FJ; Kim SJ
Mol Endocrinol; 1994 May; 8(5):595-602. PubMed ID: 8058069
[TBL] [Abstract][Full Text] [Related]
28. Identification of cis-acting sequences in the promoter of the herpes simplex virus type 1 latency-associated transcripts required for activation by nerve growth factor and sodium butyrate in PC12 cells.
Frazier DP; Cox D; Godshalk EM; Schaffer PA
J Virol; 1996 Nov; 70(11):7433-44. PubMed ID: 8892861
[TBL] [Abstract][Full Text] [Related]
29. Inducible cyclic AMP early repressor produces reactivation of latent herpes simplex virus type 1 in neurons in vitro.
Colgin MA; Smith RL; Wilcox CL
J Virol; 2001 Mar; 75(6):2912-20. PubMed ID: 11222716
[TBL] [Abstract][Full Text] [Related]
30. Effect of DNA-binding drugs on early growth response factor-1 and TATA box-binding protein complex formation with the herpes simplex virus latency promoter.
Chiang SY; Welch JJ; Rauscher FJ; Beerman TA
J Biol Chem; 1996 Sep; 271(39):23999-4004. PubMed ID: 8798634
[TBL] [Abstract][Full Text] [Related]
31. Two herpes simplex virus type 1 latency-active promoters differ in their contributions to latency-associated transcript expression during lytic and latent infections.
Chen X; Schmidt MC; Goins WF; Glorioso JC
J Virol; 1995 Dec; 69(12):7899-908. PubMed ID: 7494302
[TBL] [Abstract][Full Text] [Related]
32. Effect of the transcription start region of the herpes simplex virus type 1 latency-associated transcript promoter on expression of productively infected neurons in vivo.
Farrell MJ; Margolis TP; Gomes WA; Feldman LT
J Virol; 1994 Sep; 68(9):5337-43. PubMed ID: 8057417
[TBL] [Abstract][Full Text] [Related]
33. Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1beta.
Tan L; Peng H; Osaki M; Choy BK; Auron PE; Sandell LJ; Goldring MB
J Biol Chem; 2003 May; 278(20):17688-700. PubMed ID: 12637574
[TBL] [Abstract][Full Text] [Related]
34. The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor beta1 gene through an Egr-1 binding site.
Yoo YD; Chiou CJ; Choi KS; Yi Y; Michelson S; Kim S; Hayward GS; Kim SJ
J Virol; 1996 Oct; 70(10):7062-70. PubMed ID: 8794351
[TBL] [Abstract][Full Text] [Related]
35. Early growth response gene 1 (Egr-1) regulates HSV-1 ICP4 and ICP22 gene expression.
Bedadala GR; Pinnoji RC; Hsia SC
Cell Res; 2007 Jun; 17(6):546-55. PubMed ID: 17502875
[TBL] [Abstract][Full Text] [Related]
36. Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1.
Liu C; Adamson E; Mercola D
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11831-6. PubMed ID: 8876223
[TBL] [Abstract][Full Text] [Related]
37. The human zinc finger protein EGR-4 acts as autoregulatory transcriptional repressor.
Zipfel PF; Decker EL; Holst C; Skerka C
Biochim Biophys Acta; 1997 Nov; 1354(2):134-44. PubMed ID: 9396630
[TBL] [Abstract][Full Text] [Related]
38. Inducible PDGF A-chain transcription in smooth muscle cells is mediated by Egr-1 displacement of Sp1 and Sp3.
Silverman ES; Khachigian LM; Lindner V; Williams AJ; Collins T
Am J Physiol; 1997 Sep; 273(3 Pt 2):H1415-26. PubMed ID: 9321833
[TBL] [Abstract][Full Text] [Related]
39. Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo.
Ahmed M; Lock M; Miller CG; Fraser NW
J Virol; 2002 Jan; 76(2):717-29. PubMed ID: 11752162
[TBL] [Abstract][Full Text] [Related]
40. The TATA-less promoter of hepatitis B virus S gene contains a TBP binding site and an active initiator.
Bogomolski-Yahalom V; Klein A; Greenblat I; Haviv Y; Tur-Kaspa R
Virus Res; 1997 May; 49(1):1-7. PubMed ID: 9178491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
